alexa Marc Ladanyi
ISSN: 0974-276X

Journal of Proteomics & Bioinformatics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Marc Ladanyi

Department of Pathology,
Memorial Sloan Ketteing Cancer Center,

Marc Ladanyi is a Molecular pathologist. He studies the molecular pathogenesis of sarcomas, lung cancer, and mesothelioma. He pursued MD at McGill University. He is currently the Chief, Molecular Diagnostics Service; William J. Ruane Chair in Molecular Oncology.

Research Interest

 Cancer, Biochemistry, Molecular biology, Genetics, Proteomics


Proteomic Technologies to Develop Biomarkers and Functional Analyses for Bone and Soft Tissue Tumors

Yoshiyuki Suehara, Shinji Kohsaka, Daisuke Kubota, Kenta Mukaihara, Keisuke Akaike, Reiko Mineki, Tsutomu Fujimura, Kazuo Kaneko, Marc Ladanyi, Tsuyoshi Saito and Tadashi Kondo

Review Article: J Proteomics Bioinform S3: 001

DOI: 10.4172/jpb.S3-001

EWS-WT1 Chimeric Protein in Desmoplastic Small Round Cell Tumor is a Potent Transactivator of FGFR4

Tsuyoshi Saito, Mayumi Yokotsuka, Toru Motoi, Hiroshi Iwasaki, Toshitaka Nagao, Marc Ladanyi and Takashi Yao

Research Article: J Cancer Sci Ther/Vol.4.10 335-340 (2012)

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version